Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Y Wu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Oncogene|January 16, 2002
Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factorLiu Yang, Li Xia, Daniel Y Wu, et al.
Case Reports in Hematology|October 26, 2020
Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)Heather Klocke, Zhao Ming Dong, Craig O'Brien, et al.
Molecular Cancer Research : MCR|May 29, 2008
TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cellsJing Pan, Junhui Zou, Daniel Y Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 23, 2011
Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific NorthwestSteven B Zeliadt, Nishant K Sekaran, Elaine Y Hu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Oncogene|January 16, 2002
Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factorLiu Yang, Li Xia, Daniel Y Wu, et al.
Case Reports in Hematology|October 26, 2020
Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS)Heather Klocke, Zhao Ming Dong, Craig O'Brien, et al.
Molecular Cancer Research : MCR|May 29, 2008
TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cellsJing Pan, Junhui Zou, Daniel Y Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 23, 2011
Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific NorthwestSteven B Zeliadt, Nishant K Sekaran, Elaine Y Hu, et al.
Pageof 2